Ally Bridge Group as of Sept. 30, 2021
Portfolio Holdings for Ally Bridge Group
Ally Bridge Group holds 31 positions in its portfolio as reported in the September 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Natera (NTRA) | 8.8 | $30M | 268k | 111.44 | |
| Spdr Ser Tr Put Put Option | 7.4 | $25M | 200k | 125.71 | |
| Repligen Corporation (RGEN) | 5.9 | $20M | 70k | 288.99 | |
| Arvinas Ord (ARVN) | 5.1 | $17M | 210k | 82.18 | |
| Mirati Therapeutics | 4.9 | $17M | 95k | 176.91 | |
| Nuvation Bio Com Cl A (NUVB) | 4.9 | $17M | 1.7M | 9.94 | |
| Fate Therapeutics (FATE) | 4.7 | $16M | 270k | 59.27 | |
| Syros Pharmaceuticals | 4.5 | $15M | 3.4M | 4.47 | |
| Miragen Therapeutics (VRDN) | 4.4 | $15M | 905k | 16.45 | |
| Gossamer Bio (GOSS) | 4.3 | $15M | 1.2M | 12.57 | |
| Ideaya Biosciences (IDYA) | 4.3 | $15M | 576k | 25.49 | |
| Cogent Biosciences (COGT) | 4.0 | $14M | 1.6M | 8.41 | |
| Iovance Biotherapeutics (IOVA) | 3.0 | $10M | 407k | 24.66 | |
| Somalogic Class A Com | 2.9 | $9.9M | 800k | 12.39 | |
| Apellis Pharmaceuticals Call Call Option | 2.9 | $9.9M | 300k | 32.96 | |
| Nautilus Biotechnology (NAUT) | 2.7 | $9.2M | 1.5M | 6.14 | |
| Nanostring Technologies (NSTGQ) | 2.6 | $8.9M | 185k | 48.01 | |
| Intellia Therapeutics (NTLA) | 2.6 | $8.7M | 65k | 134.15 | |
| Medavail Holdings Ord | 2.5 | $8.5M | 2.9M | 2.92 | |
| Rapid Micro Biosystems Class A Com (RPID) | 2.4 | $8.1M | 438k | 18.47 | |
| Sight Sciences (SGHT) | 2.3 | $7.8M | 342k | 22.70 | |
| Macrogenics (MGNX) | 2.2 | $7.6M | 365k | 20.94 | |
| Invitae (NVTAQ) | 1.7 | $5.7M | 200k | 28.43 | |
| Cyteir Therapeutics | 1.6 | $5.6M | 320k | 17.55 | |
| Amyris Com New | 1.4 | $4.8M | 352k | 13.73 | |
| Leap Therapeutics | 1.4 | $4.8M | 1.2M | 4.01 | |
| Iveric Bio | 1.2 | $4.1M | 250k | 16.24 | |
| Berkeley Lts | 1.2 | $4.0M | 202k | 19.56 | |
| Adicet Bio (ACET) | 1.0 | $3.3M | 425k | 7.84 | |
| Bolt Biotherapeutics (BOLT) | 1.0 | $3.3M | 257k | 12.65 | |
| Verve Therapeutics (VERV) | 0.2 | $705k | 15k | 47.00 |
